Columbia Partners Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $1.51M | Buy |
17,806
+9,244
| +108% | +$782K | 0.59% | 52 |
|
|
2018
Q3 | $1.47M | Buy |
+8,562
| New | +$1.47M | 0.37% | 84 |
|
|
2018
Q2 | – | Sell |
-4,628
| Closed | -$476K | – | 193 |
|
|
2018
Q1 | $476K | Sell |
4,628
-7,213
| -61% | -$742K | 0.06% | 198 |
|
|
2017
Q4 | $1.01M | Sell |
11,841
-4,806
| -29% | -$410K | 0.13% | 166 |
|
|
2017
Q3 | $1.41M | Buy |
16,647
+7,217
| +77% | +$613K | 0.19% | 152 |
|
|
2017
Q2 | $714K | Sell |
9,430
-20,844
| -69% | -$1.58M | 0.09% | 192 |
|
|
2017
Q1 | $2M | Sell |
30,274
-61,350
| -67% | -$4.05M | 0.25% | 113 |
|
|
2016
Q4 | $5.81M | Sell |
91,624
-18,465
| -17% | -$1.17M | 0.52% | 64 |
|
|
2016
Q3 | $7.01M | Buy |
110,089
+38,345
| +53% | +$2.44M | 0.55% | 55 |
|
|
2016
Q2 | $5.34M | Sell |
71,744
-131
| -0.2% | -$9.75K | 0.4% | 89 |
|
|
2016
Q1 | $4.8M | Buy |
71,875
+37,303
| +108% | +$2.49M | 0.34% | 113 |
|
|
2015
Q4 | $2.34M | Buy |
+34,572
| New | +$2.34M | 0.16% | 156 |
|